Leponex (Clozapine)

Clozapine is an atypical antipsychotic used primarily in the management of schizophrenia spectrum disorders.

• Schizophrenia: Reduces positive and negative symptoms in patients who have not responded adequately to other antipsychotics.
• Schizoaffective disorder: Improves mood and psychotic symptoms when standard therapies are insufficient.
• Treatment‑resistant schizophrenia: Provides symptom control in individuals who have failed at least two prior antipsychotic trials.

• Clozapine antagonizes dopamine D2 and serotonin 5‑HT2A receptors while also blocking D4, 5‑HT2C, muscarinic, histamine H1 and adrenergic receptors. This broad receptor profile modulates dopaminergic and serotonergic neurotransmission, leading to reduction of psychotic symptoms and improvement of mood and cognition in schizophrenia spectrum disorders.

Clozapine may cause a range of adverse reactions, varying from mild to potentially life‑threatening.

Common Side Effects

• Sedation: Drowsiness or fatigue, especially early in treatment.
• Weight gain: Increased appetite leading to modest weight increase.
• Constipation: Reduced gastrointestinal motility causing infrequent stools.
• Salivation: Excessive drooling, particularly at night.

Serious or Rare Side Effects

• Agranulocytosis: Severe drop in white blood cells, necessitating regular blood monitoring.
• Myocarditis: Inflammation of the heart muscle that may cause chest pain or flu‑like symptoms.
• Seizures: Elevated risk, particularly at higher doses.
• Neuroleptic malignant syndrome: Rare syndrome with fever, muscle rigidity, and autonomic instability.

When prescribing Clozapine, clinicians should observe several safety precautions to minimize risks.

• Blood monitoring: Perform baseline and regular complete blood counts to detect agranulocytosis.
• Cardiac assessment: Evaluate for myocarditis with baseline and periodic ECG and troponin tests.
• Dose titration: Increase dose gradually to reduce seizure risk.
• Concomitant medications: Avoid drugs that lower seizure threshold or interact with clozapine metabolism.
• Patient education: Inform patients about signs of infection, cardiac symptoms, and the importance of adherence to monitoring.
• Store at ambient temperature: Keep tablets below 25 °C in the original container, protected from moisture and light.

Clozapine interacts with several medicines that can alter its plasma levels or increase toxicity.

Major Interactions (Avoid)

• Ciprofloxacin: Inhibits CYP1A2, markedly raising clozapine concentrations.
• Fluvoxamine: Strong CYP1A2 inhibitor, can cause severe clozapine toxicity.
• Carbamazepine: Induces CYP enzymes, potentially reducing clozapine efficacy.

Moderate Interactions (Monitor Closely)

• Valproic acid: May increase clozapine levels and risk of sedation.
• Benzodiazepines: Additive central nervous system depression.
• Anticholinergic agents: May worsen constipation and urinary retention.